Tower Research Capital LLC (Trc) Zai Lab LTD Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Zai Lab LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 366 shares of ZLAB stock, worth $13,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
366
Previous 1,748
79.06%
Holding current value
$13,143
Previous $42,000
78.57%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$239 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$236 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$231 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$114 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$90.1 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.52B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...